Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Sepsis

Free Subscription Articles published in Eur J Clin Microbiol Infect Dis Retrieve available abstracts of 101 articles: HTML format

Single Articles

October 2025
1. UZAR H, Karadogan E, Sertcelik A, Dizman GT, et al
   The impact of an institutional sepsis guideline on selecting appropriate empirical treatment in patients with carbapenem-resistant gram-negative bacilli bacteremia.
   Eur J Clin Microbiol Infect Dis. 2025 Oct 4. doi: 10.1007/s10096-025-05276.
   PubMed     Abstract available
   
   
   
2. GUNES O, Ozkaya-Parlakay A, Guney AY, Coskun ZN, et al
   Clinical features, antimicrobial susceptibilities, treatment characteristics and outcomes of paediatric Acinetobacter lwoffii bacteremia: a case series.
   Eur J Clin Microbiol Infect Dis. 2025;44:2539-2548.
   PubMed     Abstract available
   
   
   
3. SHALOM O, Cohen-Lerner I, Adler A
   A comparative study of the VITEK((R)) REVEAL versus the VITEK2 system in susceptibility testing of NDM-producing enterobacterales and Acinetobacter baumannii directly from positive blood cultures.
   Eur J Clin Microbiol Infect Dis. 2025;44:2509-2514.
   PubMed     Abstract available
   
   
   
4. ATAY UNAL N, Polat M, Sahin EA, Erganis S, et al
   Prevalence and risk factors of concurrent bacteremia in children under 5 years of age hospitalized with viral lower respiratory tract infections.
   Eur J Clin Microbiol Infect Dis. 2025;44:2447-2455.
   PubMed     Abstract available
   
   
   
5. PERREAU C, Ranc AG, Gillet L, Gaillard T, et al
   Molecular investigation of unexpected Helicobacter pylori bacteremia.
   Eur J Clin Microbiol Infect Dis. 2025;44:2421-2426.
   PubMed     Abstract available
   
   
   September 2025
6. JIA W, Sun R, Hou J, Ding Z, et al
   Assessment of Phoenix sepsis score: characterization of a cohort of children of different primary statuses and ages, 2020-2024.
   Eur J Clin Microbiol Infect Dis. 2025 Sep 15. doi: 10.1007/s10096-025-05255.
   PubMed     Abstract available
   
   
   
7. DUSSARTRE M, Duflot N, Valentin AS, Farizon M, et al
   Incidence trends and epidemiology of invasive device-associated bacteremia in French nursing home residents, 2020-2024: Insights from the SPIADI Prospective Multicenter Study.
   Eur J Clin Microbiol Infect Dis. 2025;44:2219-2230.
   PubMed     Abstract available
   
   
   
8. BOATTINI M, Aceti A, Bastos P, Mavromanolaki VE, et al
   A European survey on anaerobes from paediatric blood cultures: a comparative analysis with adults.
   Eur J Clin Microbiol Infect Dis. 2025;44:2207-2217.
   PubMed     Abstract available
   
   
   
9. KROLICKI T, Kudla T, Krolicka A, Bardowska K, et al
   Antibiotic practices in kidney transplant recipients with urosepsis are associated with treatment outcomes - a post-hoc analysis of an observational study.
   Eur J Clin Microbiol Infect Dis. 2025;44:2129-2138.
   PubMed     Abstract available
   
   
   August 2025
10. AYDIN TEKE T, Kaman A, Oz FN, Gayretli Aydin ZG, et al
    Granulicatella adiacens infections in children: a single-center retrospective study.
    Eur J Clin Microbiol Infect Dis. 2025;44:1873-1878.
    PubMed     Abstract available
    
    
    July 2025
11. ZHOU P, Wang X, Deng L, Li S, et al
    Predictive value of platelet count-related ratios for severity in biliary Escherichia coli and Klebsiella pneumonia bloodstream infections.
    Eur J Clin Microbiol Infect Dis. 2025;44:1597-1604.
    PubMed     Abstract available
    
    
    June 2025
12. GALLEGO ARISTIZABAL PA, Pelaez Garcia S, Caicedo Espinosa JE, Montoya-Jaramillo S, et al
    Alkalihalobacillus clausii bacteremia after probiotic use for acute diarrhea: a case report.
    Eur J Clin Microbiol Infect Dis. 2025;44:1527-1529.
    PubMed     Abstract available
    
    
    May 2025
13. YU G, Lou Y, He L, Wang Z, et al
    beta-lactam antibiotics vs vancomycin in treating methicillin-sensitive staphylococcus aureus bloodstream infections: a meta-analysis of clinical outcomes.
    Eur J Clin Microbiol Infect Dis. 2025 May 30. doi: 10.1007/s10096-025-05164.
    PubMed     Abstract available
    
    
    
14. EDWARDS F, Waller M, Laupland KB
    Determinants of time to positivity in bloodstream infections: an analysis of a population-based cohort in Queensland, Australia.
    Eur J Clin Microbiol Infect Dis. 2025;44:1197-1204.
    PubMed     Abstract available
    
    
    
15. HELOU RI, van der Sijs H, Rizopoulos D, Vogel M, et al
    The feasibility of antimicrobial lead time as process and quality indicator for hospitals.
    Eur J Clin Microbiol Infect Dis. 2025;44:1177-1183.
    PubMed     Abstract available
    
    
    
16. LEJBMAN IA, Torisson G, Resman F, Sjovall F, et al
    Higher target attainment for B-lactam antibiotics in patients with Gram-negative bloodstream infections when four times actual minimum inhibitory concentrations and epidemiological cutoff values are applied compared to clinical breakpoints.
    Eur J Clin Microbiol Infect Dis. 2025;44:1129-1137.
    PubMed     Abstract available
    
    
    April 2025
17. MENIER L, Balandraud A, Choufani C, Quere PL, et al
    Travel-related sepsis with colitis and necrotizing skin and soft tissue infection after oysters consumption.
    Eur J Clin Microbiol Infect Dis. 2025 Apr 30. doi: 10.1007/s10096-025-05146.
    PubMed     Abstract available
    
    
    
18. HANADA S, Wajima T, Takata M, Morozumi M, et al
    Additional biomarkers and emm types associated with group A streptococcal toxic shock syndrome: a Japanese nationwide observational study.
    Eur J Clin Microbiol Infect Dis. 2025 Apr 7. doi: 10.1007/s10096-025-05116.
    PubMed     Abstract available
    
    
    
19. JIANG N, Xie W, Wang D, Wang W, et al
    Early appropriate therapy with polymyxin B reduces the mortality in burn sepsis caused by carbapenem-resistant gram-negative bacteria: a retrospective analysis.
    Eur J Clin Microbiol Infect Dis. 2025 Apr 3. doi: 10.1007/s10096-025-05119.
    PubMed     Abstract available
    
    
    
20. WANDJI S, Jehanne Q, Benejat L, Ducournau A, et al
    The first two human infections with Helicobacter zhangjianzhongii, a new Helicobacter closely related to Helicobacter canis.
    Eur J Clin Microbiol Infect Dis. 2025;44:939-949.
    PubMed     Abstract available
    
    
    
21. ALMUTAWA F, Delport J
    Evaluation of a four-day incubation protocol for blood cultures: a quality improvement project.
    Eur J Clin Microbiol Infect Dis. 2025;44:933-938.
    PubMed     Abstract available
    
    
    
22. MASSART N, Ortuno S, Vidal C, Henri S, et al
    Which antimicrobial treatment for patients with bloodstream infection during ECMO support?
    Eur J Clin Microbiol Infect Dis. 2025;44:905-914.
    PubMed     Abstract available
    
    
    
23. HOLUB M, Lebeaux D, Grohs P, Joseph L, et al
    Central-venous-catheter-related bloodstream infections in adult patients with sickle cell disease: a retrospective, two-centre study.
    Eur J Clin Microbiol Infect Dis. 2025;44:877-886.
    PubMed     Abstract available
    
    
    
24. MESSIAEN AS, Vandendriessche S, De Muynck E, Strubbe G, et al
    Impact of reporting rapid susceptibility results in Gram negative bloodstream infections: a real world prospective study.
    Eur J Clin Microbiol Infect Dis. 2025;44:847-853.
    PubMed     Abstract available
    
    
    March 2025
25. LOPES D, Grandbastien B, Orasch C, Greub G, et al
    Impact of rapid identification by MALDI-TOF MS from positive blood cultures in Enterococcus spp. bloodstream infections.
    Eur J Clin Microbiol Infect Dis. 2025 Mar 8. doi: 10.1007/s10096-025-05084.
    PubMed     Abstract available
    
    
    February 2025
26. LOBO BBP, de Siqueira Caldas JP
    Trends in incidence of neonatal late-onset sepsis in very low birth weight infants: a 15-year Brazilian single center analysis.
    Eur J Clin Microbiol Infect Dis. 2025 Feb 21. doi: 10.1007/s10096-025-05074.
    PubMed     Abstract available
    
    
    
27. VERKAIK D, Westgeest AC, Wu JL, Sigaloff KCE, et al
    Clinical revenues of selective use of [18F]-FDG-PET/CT scanning in the management of Staphylococcus aureus bacteremia.
    Eur J Clin Microbiol Infect Dis. 2025 Feb 8. doi: 10.1007/s10096-025-05052.
    PubMed     Abstract available
    
    
    
28. STEWART AG, Edwards F, Harris PNA, Paterson DL, et al
    Risk of mortality in Fusobacterium species bloodstream infection from a large Australian cohort.
    Eur J Clin Microbiol Infect Dis. 2025;44:427-436.
    PubMed     Abstract available
    
    
    
29. XU L, Tang L, Qin J, Pan H, et al
    A multidisciplinary comprehensive nursing Management Approach for Catheter-related bloodstream infections.
    Eur J Clin Microbiol Infect Dis. 2025;44:365-373.
    PubMed     Abstract available
    
    
    
30. ABICHABKI N, Gaspar GG, Bortolato LR, Lima DAFS, et al
    Ceftazidime-avibactam tolerance and persistence among difficult-to-treat KPC-producing Klebsiella pneumoniae clinical isolates from bloodstream infections.
    Eur J Clin Microbiol Infect Dis. 2025;44:343-353.
    PubMed     Abstract available
    
    
    
31. KARAKOSTA P, Meletis G, Kousouli E, Protonotariou E, et al
    Rectal colonization with multidrug-resistant organisms and risk for bloodstream infection among high-risk Greek patients.
    Eur J Clin Microbiol Infect Dis. 2025;44:437-442.
    PubMed     Abstract available
    
    
    January 2025
32. WU R, Cui X, Pan R, Li N, et al
    Pathogenic characterization and drug resistance of neonatal sepsis in China: a systematic review and meta-analysis.
    Eur J Clin Microbiol Infect Dis. 2025 Jan 24. doi: 10.1007/s10096-025-05048.
    PubMed     Abstract available
    
    
    
33. BOATTINI M, Guarrasi L, Comini S, Ricciardelli G, et al
    Diagnostic methods and protocols for rapid determination of methicillin resistance in Staphylococcus aureus bloodstream infections: a comparative analysis.
    Eur J Clin Microbiol Infect Dis. 2025 Jan 22. doi: 10.1007/s10096-025-05039.
    PubMed     Abstract available
    
    
    
34. RAO J, Wang X, Deng S, Tang F, et al
    Changes in the epidemiology of neonatal bacteremia during the COVID-19 pandemic in Wuhan, China.
    Eur J Clin Microbiol Infect Dis. 2025;44:117-127.
    PubMed     Abstract available
    
    
    December 2024
35. FUKUSHIMA S, Saito T, Iwamoto Y, Takehara Y, et al
    Trends in the growing impact of group A Streptococcus infection on public health after COVID-19 pandemic: a multicentral observational study in Okayama, Japan.
    Eur J Clin Microbiol Infect Dis. 2024 Dec 16. doi: 10.1007/s10096-024-05015.
    PubMed     Abstract available
    
    
    
36. HINCAPIE-OSORNO C, van Wijk RJ, Postma DF, Koeze J, et al
    Validation of MEWS, NEWS, NEWS-2 and qSOFA for different infection foci at the emergency department, the acutelines cohort.
    Eur J Clin Microbiol Infect Dis. 2024;43:2441-2452.
    PubMed     Abstract available
    
    
    
37. SAKOH T, Miyajima E, Endo Y, Baba M, et al
    Cefiderocol susceptibility of 146 Stenotrophomonas maltophilia strains clinically isolated from blood in two Japanese hospitals over a 10-year period.
    Eur J Clin Microbiol Infect Dis. 2024;43:2485-2488.
    PubMed     Abstract available
    
    
    
38. BORCAN AM, Vasile CC, Popa AI, Badea CA, et al
    Pseudo-outbreak of Bacillaceae species associated with poor compliance with blood culture collection recommendations.
    Eur J Clin Microbiol Infect Dis. 2024;43:2335-2340.
    PubMed     Abstract available
    
    
    
39. ZHUO R, Younes RL, Ward K, Yang S, et al
    Carbapenem resistant Campylobacter jejuni bacteremia in a Bruton's X-linked agammaglobulinemia patient.
    Eur J Clin Microbiol Infect Dis. 2024;43:2459-2463.
    PubMed     Abstract available
    
    
    November 2024
40. MADRAN B, Keske S, Ferhanoglu B, Mandel NM, et al
    The long-term impact of an antimicrobial stewardship program in febrile neutropenia: an 8 years follow up.
    Eur J Clin Microbiol Infect Dis. 2024;43:2171-2176.
    PubMed     Abstract available
    
    
    
41. AI G, Zhang Y, Guo K, Zhao L, et al
    The impact of optimizing microbial diagnosis processes on clinical and healthcare economic outcomes in hospitalized patients with bloodstream infections.
    Eur J Clin Microbiol Infect Dis. 2024;43:2147-2157.
    PubMed     Abstract available
    
    
    
42. TAKI Y, Sato S, Watanabe M, Ohata K, et al
    Development and validation of a predictive model for in-hospital mortality from perioperative bacteremia in gastrointestinal surgery.
    Eur J Clin Microbiol Infect Dis. 2024;43:2117-2126.
    PubMed     Abstract available
    
    
    
43. ADOUANE M, Kadri N, Benzitoune N, Lakhdari C, et al
    Understanding bacterial diversity, infection dynamics, prevention of antibiotic resistance: an integrated study in an Algerian hospital context.
    Eur J Clin Microbiol Infect Dis. 2024;43:2093-2105.
    PubMed     Abstract available
    
    
    October 2024
44. SCHULER F, Kaasch AJ, Schaumburg F
    Molecular detection of Staphylococcus aureus in urine in patients with S. aureus bacteremia: an exploratory study.
    Eur J Clin Microbiol Infect Dis. 2024 Oct 31. doi: 10.1007/s10096-024-04969.
    PubMed     Abstract available
    
    
    
45. YU D, Ekwall-Larson A, Ozenci V
    Performance of T2Bacteria in relationship to blood cultures - a retrospective comparative study.
    Eur J Clin Microbiol Infect Dis. 2024;43:1977-1987.
    PubMed     Abstract available
    
    
    
46. TURKELTAUB L, Kashat L, Assous MV, Adler K, et al
    Estimating bacterial load in S. aureus and E. coli bacteremia using bacterial growth graph from the continuous monitoring blood culture system.
    Eur J Clin Microbiol Infect Dis. 2024;43:1931-1938.
    PubMed     Abstract available
    
    
    September 2024
47. WENZEL A, Roder J, Poos T, Dusse F, et al
    Economic effects of next-generation sequencing diagnostics in unspecific sepsis patients - a budget impact analysis from the healthcare providers' perspective in Germany.
    Eur J Clin Microbiol Infect Dis. 2024 Sep 24. doi: 10.1007/s10096-024-04940.
    PubMed     Abstract available
    
    
    
48. WU C, Yuan Y, Tang S, Liu C, et al
    Clinical and microbiological features of a cohort of patients with Acinetobacter baumannii bloodstream infections.
    Eur J Clin Microbiol Infect Dis. 2024;43:1721-1730.
    PubMed     Abstract available
    
    
    
49. PALOMBO M, Gatti M, Secci B, Cojutti PG, et al
    Effect of incremental tazobactam concentrations on the bactericidal activity of piperacillin against ESBL-producing enterobacterales clinical isolates causing bacteraemia.
    Eur J Clin Microbiol Infect Dis. 2024;43:1861-1864.
    PubMed     Abstract available
    
    
    
50. CHIANG TT, Chiang MH, Tang HJ, Shi ZY, et al
    Multicenter study on clinical outcomes and poor prognostic factors in patients with Klebsiella pneumoniae bacteremia receiving cefoperazone/sulbactam treatment.
    Eur J Clin Microbiol Infect Dis. 2024;43:1777-1785.
    PubMed     Abstract available
    
    
    
51. GASSIEP I, Edwards F, Laupland KB
    Epidemiology of biliary tract-associated bloodstream infections and adequacy of empiric therapy: an Australian population-based study.
    Eur J Clin Microbiol Infect Dis. 2024;43:1753-1760.
    PubMed     Abstract available
    
    
    
52. HERRERA F, Torres D, Laborde A, Jordan R, et al
    Seven-day antibiotic therapy for Enterobacterales bacteremia in high-risk neutropenic patients: toward a new paradigm.
    Eur J Clin Microbiol Infect Dis. 2024;43:1741-1751.
    PubMed     Abstract available
    
    
    
53. BERGMANN F, Jorda A, Sollner J, Sawodny R, et al
    Prevalence and clinical implications of bloodstream infections in intensive care patients with or without burn injury: a retrospective cohort study.
    Eur J Clin Microbiol Infect Dis. 2024;43:1731-1740.
    PubMed     Abstract available
    
    
    August 2024
54. SCHARLOO F, Cogliati Dezza F, Lopez-Hernandez I, Martinez Perez-Crespo PM, et al
    Clinical characteristics, predisposing factors and outcomes for Enterococcus faecalis versus Enterococcus faecium bloodstream infections: a prospective multicentre cohort study.
    Eur J Clin Microbiol Infect Dis. 2024 Aug 8. doi: 10.1007/s10096-024-04917.
    PubMed     Abstract available
    
    
    
55. DIEGO-YAGUE I, Ramos-Martinez A, Munoz P, Martinez-Selles M, et al
    Clinical features and prognosis of prosthetic valve endocarditis due to Staphylococcus aureus.
    Eur J Clin Microbiol Infect Dis. 2024 Aug 7. doi: 10.1007/s10096-024-04848.
    PubMed     Abstract available
    
    
    
56. JAUVAIN M, Carrer M, Palma F, Chapuzet C, et al
    Bacteraemia associated with multiple septic localizations caused by Klebsiella pneumoniae sequence type ST660.
    Eur J Clin Microbiol Infect Dis. 2024;43:1655-1659.
    PubMed     Abstract available
    
    
    
57. BONNEFOY C, Vannini M, Degand N, Gaudart A, et al
    Multiplex microarray PCR Unyvero BCU system to accelerate relevant antimicrobial treatment in polymicrobial bloodstream infection.
    Eur J Clin Microbiol Infect Dis. 2024;43:1545-1557.
    PubMed     Abstract available
    
    
    July 2024
58. SOLANKI P, Colaco C, Dotel R
    Analysis of bacteraemia caused by group C and G Streptococcus (Streptococcus dysgalactiae subsp. equisimilis) in Western Sydney over a 6-year period (2015-2020).
    Eur J Clin Microbiol Infect Dis. 2024 Jul 15. doi: 10.1007/s10096-024-04903.
    PubMed     Abstract available
    
    
    
59. COLLAR GDS, Becker J, Moreira NK, Dornelles LS, et al
    Rapid colorimetric polymyxin B microelution directly from positive blood bottles: because patients with serious infections should not have to wait for results of culture-based methodologies.
    Eur J Clin Microbiol Infect Dis. 2024;43:1407-1417.
    PubMed     Abstract available
    
    
    June 2024
60. OLIVA A, Liguori L, Covino S, Petrucci F, et al
    Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era: a single center, observational study.
    Eur J Clin Microbiol Infect Dis. 2024;43:1149-1160.
    PubMed     Abstract available
    
    
    
61. CASPAR Y, Deves A, Richarme C, Le Marechal M, et al
    Clinical impact and cost-consequence analysis of ePlex(R) blood culture identification panels for the rapid diagnosis of bloodstream infections: a single-center randomized controlled trial.
    Eur J Clin Microbiol Infect Dis. 2024;43:1193-1203.
    PubMed     Abstract available
    
    
    
62. KARAKOSTA P, Vourli S, Kousouli E, Meletis G, et al
    Multidrug-resistant organism bloodstream infection and hospital acquisition among inpatients in three tertiary Greek hospitals during the COVID-19 era.
    Eur J Clin Microbiol Infect Dis. 2024;43:1241-1246.
    PubMed     Abstract available
    
    
    May 2024
63. MOTRO Y, Temper V, Strahilevitz J, Moran-Gilad J, et al
    Invasive infections caused by the recently described species Enterococcus innesii.
    Eur J Clin Microbiol Infect Dis. 2024 May 29. doi: 10.1007/s10096-024-04864.
    PubMed     Abstract available
    
    
    
64. BERGENMAN O, Nilson B, Rasmussen M
    Risk of infective endocarditis and complicated infection in Staphylococcus aureus bacteremia - a retrospective cohort study on the role of bacteriuria.
    Eur J Clin Microbiol Infect Dis. 2024 May 21. doi: 10.1007/s10096-024-04850.
    PubMed     Abstract available
    
    
    
65. PEREZ-RODRIGUEZ MT, Lima O, Garrido M, Rincon A, et al
    The role of time to positive blood cultures in enhancing the predictive capability of DENOVA score for diagnosing infective endocarditis in patients with Enterococcus faecalis bacteremia.
    Eur J Clin Microbiol Infect Dis. 2024 May 20. doi: 10.1007/s10096-024-04843.
    PubMed     Abstract available
    
    
    
66. ASMAH RH, Squire DS, Adupko S, Adedia D, et al
    Host-parasite interaction in severe and uncomplicated malaria infection in ghanaian children.
    Eur J Clin Microbiol Infect Dis. 2024;43:915-926.
    PubMed     Abstract available
    
    
    April 2024
67. ILSBY CS, Hertz FB, Westh H, Monk J, et al
    Predicting the primary infection source of Escherichia coli bacteremia using virulence-associated genes.
    Eur J Clin Microbiol Infect Dis. 2024;43:641-648.
    PubMed     Abstract available
    
    
    March 2024
68. OLDENDORFF F, Nordberg V, Giske CG, Naver L, et al
    A decade of neonatal sepsis in Stockholm, Sweden: Gram-positive pathogens were four times as common as Gram-negatives.
    Eur J Clin Microbiol Infect Dis. 2024 Mar 22. doi: 10.1007/s10096-024-04809.
    PubMed     Abstract available
    
    
    
69. DERMOTA U, Sturm AC, Triglav T, Smrdel KS, et al
    Whole genome sequencing and molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated from patients with bacteraemia in Slovenia.
    Eur J Clin Microbiol Infect Dis. 2024 Mar 22. doi: 10.1007/s10096-024-04802.
    PubMed     Abstract available
    
    
    
70. CALPENA-MARTINEZ S, Carrasco-Anton N, Cleary-Martin C, Hernandez-Estefania R, et al
    An unusual case of endotipsitis: persistent infection and migration to the right atrium of a transjugular intrahepatic portosystemic shunt (TIPS).
    Eur J Clin Microbiol Infect Dis. 2024;43:623-626.
    PubMed     Abstract available
    
    
    
71. PEIRANO G, Matsumara Y, Nobrega D, Church D, et al
    Population-based genomic surveillance of Pseudomonas aeruginosa causing bloodstream infections in a large Canadian health region.
    Eur J Clin Microbiol Infect Dis. 2024;43:501-510.
    PubMed     Abstract available
    
    
    
72. NAGAOKA K, Iwanaga N, Takegoshi Y, Murai Y, et al
    Mortality risk factors and fulminant sub-phenotype in anaerobic bacteremia: a 10-year retrospective, multicenter, observational cohort study.
    Eur J Clin Microbiol Infect Dis. 2024;43:459-467.
    PubMed     Abstract available
    
    
    
73. CRUZ S, Abreu D, Gomes R, Martins-Oliveira I, et al
    An improved protocol for bacteria identification by MALDI-TOF MS directly from positive blood cultures.
    Eur J Clin Microbiol Infect Dis. 2024;43:605-610.
    PubMed     Abstract available
    
    
    February 2024
74. KIM T, Lee SR, Park SY, Moon SM, et al
    Validation of a new risk stratification system-based management for methicillin-resistant Staphylococcus aureus bacteraemia: analysis of a multicentre prospective study.
    Eur J Clin Microbiol Infect Dis. 2024 Feb 27. doi: 10.1007/s10096-024-04790.
    PubMed     Abstract available
    
    
    
75. DIEZ-VIDAL A, Gonzalez-Garcia ME, Marco-Clement I, Azores-Moreno J, et al
    Recurrent bacteremia and endocarditis due to Staphylococcus capitis in a patient with Bowen's disease: a case report.
    Eur J Clin Microbiol Infect Dis. 2024 Feb 20. doi: 10.1007/s10096-024-04783.
    PubMed     Abstract available
    
    
    
76. HERRMANN J, Burgener-Gasser AV, Goldenberger D, Roth J, et al
    Cefepime versus carbapenems for treatment of AmpC beta-lactamase-producing Enterobacterales bloodstream infections.
    Eur J Clin Microbiol Infect Dis. 2024;43:213-221.
    PubMed     Abstract available
    
    
    January 2024
77. BOATTINI M, Bianco G, Bastos P, Comini S, et al
    Prevalence and mortality of ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae bloodstream infections (2018-2022).
    Eur J Clin Microbiol Infect Dis. 2024;43:155-166.
    PubMed     Abstract available
    
    
    December 2023
78. MERIEN A, Bacle A, Tattevin P, Bellasfar D, et al
    Effectiveness of a multimodal intervention to improve blood culture collection in an adult emergency department.
    Eur J Clin Microbiol Infect Dis. 2023;42:1519-1522.
    PubMed     Abstract available
    
    
    November 2023
79. VECILLA DF, Grande JR, Valcarcel NF, Toboso MCN, et al
    Two episodes of bacteremia of zoonotic origin caused by different Streptococcus canis isolates in the same patient within a time span of 1 year.
    Eur J Clin Microbiol Infect Dis. 2023 Nov 24. doi: 10.1007/s10096-023-04718.
    PubMed     Abstract available
    
    
    
80. LESENS O, Forestier E, Botelho-Nevers E, Pavese P, et al
    Comparing ethanol lock therapy versus vancomycin lock in a salvation strategy for totally implantable vascular access device infections due to coagulase-negative staphylococci (the ETHALOCK study): a prospective double-blind randomized clinical trial.
    Eur J Clin Microbiol Infect Dis. 2023 Nov 23. doi: 10.1007/s10096-023-04702.
    PubMed     Abstract available
    
    
    
81. LOHIKOSKI R, Oldberg K, Rasmussen M
    Bacteraemia caused by non-faecalis and non-faecium Enterococcus species-a retrospective study of incidence, focus of infection, and prognosis.
    Eur J Clin Microbiol Infect Dis. 2023 Nov 3. doi: 10.1007/s10096-023-04690.
    PubMed     Abstract available
    
    
    
82. LIU F, Shao X, Dong Z, Tang K, et al
    Clinical characteristics and prognostic risk factors of candidemia in non-neutropenic patients: a retrospective cohort study.
    Eur J Clin Microbiol Infect Dis. 2023;42:1389-1394.
    PubMed     Abstract available
    
    
    October 2023
83. LEE JY, Kim ES, Chang E, Bae S, et al
    Clinical impact of metformin exposure during Staphylococcus aureus bacteremia in patients with diabetes mellitus.
    Eur J Clin Microbiol Infect Dis. 2023 Oct 18. doi: 10.1007/s10096-023-04679.
    PubMed     Abstract available
    
    
    
84. DAOUD L, Allam M, Collyns T, Ghazawi A, et al
    Extreme resistance to the novel siderophore-cephalosporin cefiderocol in an extensively drug-resistant Klebsiella pneumoniae strain causing fatal pneumonia with sepsis: genomic analysis and synergistic combinations for resistance reversal.
    Eur J Clin Microbiol Infect Dis. 2023 Oct 13. doi: 10.1007/s10096-023-04671.
    PubMed     Abstract available
    
    
    
85. IZCI F, Ture Z, Dinc G, Yay AH, et al
    The efficacy of mesenchymal stem cell treatment and colistin-fosfomycin combination on colistin-resistant Acinetobacter baumannii sepsis model.
    Eur J Clin Microbiol Infect Dis. 2023 Oct 9. doi: 10.1007/s10096-023-04674.
    PubMed     Abstract available
    
    
    
86. ONAL U, Akyol D, Kaya A, Baskol D, et al
    Ertapenem plus meropenem combination treatment in carbapenem-resistant Klebsiella pneumoniae bacteremia: an analysis of 53 cases.
    Eur J Clin Microbiol Infect Dis. 2023;42:1269-1273.
    PubMed     Abstract available
    
    
    August 2023
87. DAR S, Erickson D, Manca C, Lozy T, et al
    The impact of COVID on bacterial sepsis.
    Eur J Clin Microbiol Infect Dis. 2023 Aug 19. doi: 10.1007/s10096-023-04655.
    PubMed     Abstract available
    
    
    
88. TELLAPRAGADA C, Ostlund H, Giske C, Rasmussen M, et al
    Recurrent bacteremia with Enterococcus faecalis, the clinical findings predicting endocarditis, and genomic characterization of the isolates: a retrospective cohort study.
    Eur J Clin Microbiol Infect Dis. 2023;42:1001-1009.
    PubMed     Abstract available
    
    
    
89. KRIFORS A, Karlsson L, Ekman M, Lorant C, et al
    The kinetics of SARS-CoV-2 viremia in COVID-19 patients receiving remdesivir.
    Eur J Clin Microbiol Infect Dis. 2023;42:951-958.
    PubMed     Abstract available
    
    
    July 2023
90. GALANI I, Papoutsaki V, Karaiskos I, Moustakas N, et al
    In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream infections in Greece, 2020-2021: a multicenter study.
    Eur J Clin Microbiol Infect Dis. 2023;42:843-852.
    PubMed     Abstract available
    
    
    
91. DAVIES PJB, Jones TPW, Macleod M
    An assessment of the downstream implications of blood culture collection and transit.
    Eur J Clin Microbiol Infect Dis. 2023;42:835-842.
    PubMed     Abstract available
    
    
    
92. BARRY R, Houlihan E, Knowles SJ, Eogan M, et al
    Antenatal pyelonephritis: a three-year retrospective cohort study of two Irish maternity centres.
    Eur J Clin Microbiol Infect Dis. 2023;42:827-833.
    PubMed     Abstract available
    
    
    June 2023
93. KIM KJ, Yun SG, Cho Y, Nam MH, et al
    Evaluation of a sterile, filter-based, in-house method for rapid direct bacterial identification and antimicrobial susceptibility testing using positive blood culture.
    Eur J Clin Microbiol Infect Dis. 2023;42:691-700.
    PubMed     Abstract available
    
    
    May 2023
94. CORREDOIRA J, Miguez E, Mateo LM, Fernandez-Rodriguez R, et al
    The interaction between liver cirrhosis, infection by Streptococcus bovis, and colon cancer.
    Eur J Clin Microbiol Infect Dis. 2023 May 5. doi: 10.1007/s10096-023-04618.
    PubMed     Abstract available
    
    
    April 2023
95. NEVANLINNA V, Huttunen R, Aittoniemi J, Luukkaala T, et al
    Incidence, seasonal pattern, and clinical manifestations of Streptococcus dysgalactiae subspecies equisimilis bacteremia; a population-based study.
    Eur J Clin Microbiol Infect Dis. 2023 Apr 29. doi: 10.1007/s10096-023-04607.
    PubMed     Abstract available
    
    
    
96. DI BELLA S, Gatti M, Principe L
    Ceftriaxone for methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia: a matter of dosages?
    Eur J Clin Microbiol Infect Dis. 2023 Apr 29. doi: 10.1007/s10096-023-04612.
    PubMed    
    
    
    
97. BOATTINI M, Bianco G, Charrier L, Comini S, et al
    Rapid diagnostics and ceftazidime/avibactam for KPC-producing Klebsiella pneumoniae bloodstream infections: impact on mortality and role of combination therapy.
    Eur J Clin Microbiol Infect Dis. 2023;42:431-439.
    PubMed     Abstract available
    
    
    March 2023
98. GARRINE M, Quinto L, Costa SS, Messa A Jr, et al
    Epidemiology and clinical presentation of community-acquired Staphylococcus aureus bacteraemia in children under 5 years of age admitted to the Manhica District Hospital, Mozambique, 2001-2019.
    Eur J Clin Microbiol Infect Dis. 2023.
    PubMed     Abstract available
    
    
    
99. BERGE A, Carlsen C, Petropoulos A, Gadler F, et al
    Staphylococcus aureus bacteraemia, cardiac implantable electronic device, and the risk of endocarditis: a retrospective population-based cohort study.
    Eur J Clin Microbiol Infect Dis. 2023 Mar 15. doi: 10.1007/s10096-023-04585.
    PubMed     Abstract available
    
    
    
100. HURLEY JC
     Staphylococcus aureus hitchhiking from colonization to bacteremia via Candida within ICU infection prevention studies: a proof of concept modelling.
     Eur J Clin Microbiol Infect Dis. 2023 Mar 6. doi: 10.1007/s10096-023-04573.
     PubMed     Abstract available
     
     
     February 2023
101. YETMAR ZA, Khodadadi RB, Go JR, Chesdachai S, et al
     Post-treatment outcomes of ceftriaxone versus antistaphylococcal penicillins or cefazolin for definitive therapy of methicillin-susceptible Staphylococcus aureus bacteremia.
     Eur J Clin Microbiol Infect Dis. 2023 Feb 17. doi: 10.1007/s10096-023-04575.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Sepsis is free of charge.